Cargando…

Safety and efficiency of molnupiravir for COVID-19 patients with advanced chronic kidney disease

Detalles Bibliográficos
Autores principales:	Dufour, Inès, Devresse, Arnaud, Scohy, Anais, Briquet, Caroline, Georgery, Hélène, Delaey, Philippe, Greef, Julien De, Goffin, Eric, Labriola, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Nephrology 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085722/ https://www.ncbi.nlm.nih.gov/pubmed/37037486 http://dx.doi.org/10.23876/j.krcp.22.194

Ejemplares similares

Better late than never: eventual seroconversion against SARS-CoV-2 in a kidney transplant recipient after repeated immune challenge and monoclonal antibody therapy
por: De Greef, Julien, et al.
Publicado: (2021)

High response rate to BNT162b2 mRNA COVID-19 vaccine among self-care dialysis patients
por: Georgery, Hélène, et al.
Publicado: (2021)

In Reply to ‘Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations’
por: Fernandes, Guillaume, et al.
Publicado: (2022)

Evaluation of a commercial interferon-γ release assay for the detection of SARS-CoV-2 T-cell response after vaccination
por: Saad Albichr, Imane, et al.
Publicado: (2023)

Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies
por: Lambert, Catherine, et al.
Publicado: (2022)

Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series
por: Fernandes, Guillaume, et al.
Publicado: (2022)

COVID-19 Infection in Kidney Transplant Recipients: A Single-Center Case Series of 22 Cases From Belgium
por: Devresse, Arnaud, et al.
Publicado: (2020)

Safety, Efficacy, and Relapse of Nirmatrelvir-Ritonavir in Kidney Transplant Recipients Infected With SARS-CoV-2
por: Devresse, Arnaud, et al.
Publicado: (2022)

Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
por: Devresse, Arnaud, et al.
Publicado: (2022)

Lessons for the clinical nephrologist: lumasiran as the future cornerstone treatment for patients with primary hyperoxaluria type 1?
por: Gillion, Valentine, et al.
Publicado: (2022)

Molnupiravir efficacy among immunocompromised patients with COVID-19: no proof of concept
por: Guermazi, Dorra, et al.
Publicado: (2023)

On the choice of Molnupiravir and Paxlovid as the only antivirals permitted for COVID-19 infection in Australia
por: Boretti, Alberto
Publicado: (2023)

Sino-Orbital Aspergillosis in a Kidney Transplant Recipient
por: Maalouli, Christian, et al.
Publicado: (2022)

Molnupiravir; molecular and functional descriptors of mitochondrial safety
por: Wallace, K.B., et al.
Publicado: (2022)

Efficacy and safety of molnupiravir for COVID-19 patients
por: Fatima, Maurish, et al.
Publicado: (2022)

Simultaneous nephrectomy during kidney transplantation for polycystic kidney disease does not detrimentally impact comorbidity and graft survival
por: Darius, Tom, et al.
Publicado: (2022)

Humoral responses to BNT162b2 SARS-CoV-2 and hepatitis B vaccines are associated in patients on maintenance hemodialysis: a single-centre experience in Belgium
por: Van Regemorter, Elliott, et al.
Publicado: (2021)

Acute and Severe Hypercalcemia Early After Kidney Transplantation in a Patient Previously Treated With Etelcalcetide
por: Foguenne, Maxime, et al.
Publicado: (2023)

A Swelling in the Mouth in a Chronic Hemodialysis Patient
por: Devresse, Arnaud, et al.
Publicado: (2016)

Influence of hemodialysis on pramipexole pharmacokinetics: Lessons from two cases and literature review
por: Hanset, Nicolas, et al.
Publicado: (2019)

Severe hypercalcaemia early after kidney transplantation in two patients with severe secondary hyperparathyroidism previously treated with etelcalcetide
por: Dachy, Guillaume, et al.
Publicado: (2021)

A comparative analysis of the outcomes of patients with influenza or COVID-19 in a tertiary hospital in Belgium
por: Wallemacq, Silvio, et al.
Publicado: (2022)

Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022)

Computational Analysis of Molnupiravir
por: Sharov, Artem V., et al.
Publicado: (2022)

Molnupiravir for COVID-19
Publicado: (2022)

Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India
por: Sinha, Shubhadeep, et al.
Publicado: (2022)

Nirmatrelvir-ritonavir chez les patients greffés rénaux infectés par le SARS-CoV-2 : l’expérience d’une cohorte belge
por: Devresse, A., et al.
Publicado: (2022)

Efficacy and safety of Molnupiravir in COVID-19 patients: a systematic review
por: Mali, Kalpana Ramanna, et al.
Publicado: (2022)

5S solutions to promote medication efficiency and safety
por: Moore, Amber J.S., et al.
Publicado: (2023)

AKI and Transaminitis in a Kidney Transplant Patient
por: Lacave, Florian, et al.
Publicado: (2023)

How to manage cigarette smoking in kidney transplant candidates and recipients?
por: Devresse, Arnaud, et al.
Publicado: (2021)

Molnupiravir and Nirmatrelvir/Ritonavir: Tolerability, Safety, and Adherence in a Retrospective Cohort Study
por: Mazzitelli, Maria, et al.
Publicado: (2023)

Publisher Correction: Molnupiravir: coding for catastrophe
por: Malone, Brandon, et al.
Publicado: (2021)

Molnupiravir, une affaire franco-européenne
por: Manus, Jean-Marie
Publicado: (2021)

Molnupiravir: From Hope to Epic Fail?
por: Focosi, Daniele
Publicado: (2022)

Why Molnupiravir Fails in Hospitalized Patients
por: Brown, Ashley N., et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 infection in health care workers of a teaching hospital in Belgium: self-reported occupational and household risk factors for seropositivity
por: Scohy, Anaïs, et al.
Publicado: (2021)

Operating room data management: improving efficiency and safety in a surgical block
por: Agnoletti, Vanni, et al.
Publicado: (2013)

Antiviral Efficacy of Molnupiravir for COVID-19 Treatment
por: Bai, Yuan, et al.
Publicado: (2022)

Concise two-step chemical synthesis of molnupiravir
por: Pereira, Vinícius R. D., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m167e95chkspqpvn25fteqd22b